Farhad Ali

Array ( [id] => 3659617 [patent_doc_number] => 05656473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Human Dmk receptor' [patent_app_type] => 1 [patent_app_number] => 8/374834 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11628 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656473.pdf [firstpage_image] =>[orig_patent_app_number] => 374834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3858881 [patent_doc_number] => 05705625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Nucleic Acid Encoding novel protein tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/357598 [patent_app_country] => US [patent_app_date] => 1994-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 16219 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705625.pdf [firstpage_image] =>[orig_patent_app_number] => 357598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655637 [patent_doc_number] => 05658756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'CDNA encoding a novel human protein tyrosine phosphatase' [patent_app_type] => 1 [patent_app_number] => 8/348006 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 13035 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658756.pdf [firstpage_image] =>[orig_patent_app_number] => 348006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775499 [patent_doc_number] => 05808025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Chimeric selectins as simultaneous blocking agents for component selectin function' [patent_app_type] => 1 [patent_app_number] => 8/340539 [patent_app_country] => US [patent_app_date] => 1994-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 8761 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808025.pdf [firstpage_image] =>[orig_patent_app_number] => 340539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693627 [patent_doc_number] => 05618678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Methods for detecting PDGF agonist or antagonist activity using PDGF .alpha .' [patent_app_type] => 1 [patent_app_number] => 8/340754 [patent_app_country] => US [patent_app_date] => 1994-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4878 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618678.pdf [firstpage_image] =>[orig_patent_app_number] => 340754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995165 [patent_doc_number] => 05922562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Nucleic acids encoding transferrin receptors' [patent_app_type] => 1 [patent_app_number] => 8/337483 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 141 [patent_figures_cnt] => 145 [patent_no_of_words] => 70377 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922562.pdf [firstpage_image] =>[orig_patent_app_number] => 337483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886300 [patent_doc_number] => 05723437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'CD6 ligand' [patent_app_type] => 1 [patent_app_number] => 8/333350 [patent_app_country] => US [patent_app_date] => 1994-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 13166 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723437.pdf [firstpage_image] =>[orig_patent_app_number] => 333350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647019 [patent_doc_number] => 05639634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Cadherin polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/332643 [patent_app_country] => US [patent_app_date] => 1994-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7422 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639634.pdf [firstpage_image] =>[orig_patent_app_number] => 332643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3702983 [patent_doc_number] => 05646250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Cadherin polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/332638 [patent_app_country] => US [patent_app_date] => 1994-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14758 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646250.pdf [firstpage_image] =>[orig_patent_app_number] => 332638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886633 [patent_doc_number] => 05714458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Stable pharmaceutical compositions containing a fibroblast growth factor' [patent_app_type] => 1 [patent_app_number] => 8/325632 [patent_app_country] => US [patent_app_date] => 1994-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7989 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714458.pdf [firstpage_image] =>[orig_patent_app_number] => 325632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805236 [patent_doc_number] => 05854043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'MEKK-related signal transduction kinases' [patent_app_type] => 1 [patent_app_number] => 8/323460 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 66 [patent_no_of_words] => 24763 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854043.pdf [firstpage_image] =>[orig_patent_app_number] => 323460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664804 [patent_doc_number] => 05599676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Method for isolating a novel receptor for .alpha.4 integrins' [patent_app_type] => 1 [patent_app_number] => 8/323199 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15330 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599676.pdf [firstpage_image] =>[orig_patent_app_number] => 323199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693358 [patent_doc_number] => 05650299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Cells producing stem cell proliferation factor' [patent_app_type] => 1 [patent_app_number] => 8/319165 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 31 [patent_no_of_words] => 23127 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650299.pdf [firstpage_image] =>[orig_patent_app_number] => 319165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525887 [patent_doc_number] => 05582822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Treatment of leukemia using interleukin 2' [patent_app_type] => 1 [patent_app_number] => 8/315890 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2538 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/582/05582822.pdf [firstpage_image] =>[orig_patent_app_number] => 315890 [rel_patent_id] =>[rel_patent_doc_number] =>)